{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:54:34Z","timestamp":1794322474066,"version":"4.9.0"},"reference-count":140,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>Blood urea nitrogen and serum creatinine are imperfect markers of kidney function because they are influenced by many renal and nonrenal factors independent of kidney function. A biomarker that is released directly into the blood or urine by the kidney in response to injury may be a better early marker of drug-induced kidney toxicity than blood urea nitrogen and serum creatinine. Urine albumin and urine protein, as well as urinary markers kidney injury molecule-1 (KIM-1), \u03b22-microglobulin (B2M), cystatin C, clusterin, and trefoil factor-3 (TFF-3) have been accepted by the Food and Drug Administration and European Medicines Agency as highly sensitive and specific urinary biomarkers to monitor drug-induced kidney injury in preclinical studies and on a case-by-case basis in clinical trials. Other biomarkers of drug-induced kidney toxicity that have been detected in the urine of rodents or patients include IL-18, neutrophil gelatinase-associated lipocalin, netrin-1, liver-type fatty acid\u2013binding protein (L-FABP), urinary exosomes, and TIMP2 (insulin-like growth factor\u2013binding protein 7)\/IGFBP7 (insulin-like growth factor\u2013binding protein 7), also known as NephroCheck, the first Food and Drug Administration\u2013approved biomarker testing platform to detect acute kidney injury in patients. In the future, a combined use of functional and damage markers may advance the field of biomarkers of drug-induced kidney toxicity. Earlier detection of drug-induced kidney toxicity with a kidney-specific biomarker may result in the avoidance of nephrotoxic agents in clinical studies and may allow for earlier intervention to repair damaged kidneys.<\/jats:p>","DOI":"10.1097\/ftd.0000000000000589","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T17:50:06Z","timestamp":1544550606000},"page":"213-226","source":"Crossref","is-referenced-by-count":271,"title":["Biomarkers of Drug-Induced Kidney Toxicity"],"prefix":"10.1097","volume":"41","author":[{"given":"Benjamin R.","family":"Griffin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Faubel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Edelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.tox.2007.12.024","article-title":"Biomarkers of nephrotoxic acute kidney injury","volume":"245","author":"Ferguson","year":"2008","journal-title":"Toxicology."},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/bcp.12282","article-title":"Urinary kidney biomarkers for early detection of nephrotoxicity in clinical drug development","volume":"77","author":"van Meer","year":"2014","journal-title":"Br J Clin Pharmacol."},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.2215\/CJN.02070606","article-title":"Defining acute renal failure: RIFLE and beyond","volume":"1","author":"Van Biesen","year":"2006","journal-title":"Clin J Am Soc Nephrol."},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00134-006-0478-x","article-title":"Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria","volume":"33","author":"Bellomo","year":"2007","journal-title":"Intensive Care Med."},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2215\/CJN.02560706","article-title":"Can we rely on blood urea nitrogen as a biomarker to determine when to initiate dialysis?","volume":"1","author":"Waikar","year":"2006","journal-title":"Clin J Am Soc Nephrol."},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/ki.1980.84","article-title":"Determinants of ureagenesis, with particular reference to renal failure","volume":"17","author":"Walser","year":"1980","journal-title":"Kidney Int."},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM198111123052010","article-title":"Uremia and the BUN","volume":"305","author":"Luke","year":"1981","journal-title":"N Engl J Med."},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1046\/j.1523-1755.1998.00210.x","article-title":"Treatment of acute renal failure","volume":"54","author":"Star","year":"1998","journal-title":"Kidney Int."},{"key":"R10-20230814","first-page":"509","article-title":"Serum chemistry and hematological adaptations to 6 weeks of moderate to intense resistance training","volume":"16","author":"Kilgore","year":"2002","journal-title":"J Strength Cond Res."},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7812\/tpp\/11-121","article-title":"False estimates of elevated creatinine","volume":"16","author":"Samra","year":"2012","journal-title":"Perm J."},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5414\/CNP64041","article-title":"Serum cystatin C\u2014a superior marker of rapidly reduced glomerular filtration after uninephrectomy in kidney donors compared to creatinine","volume":"64","author":"Herget-Rosenthal","year":"2005","journal-title":"Clin Nephrol."},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/ki.1985.101","article-title":"Course of acute renal failure studied by a model of creatinine kinetics","volume":"27","author":"Moran","year":"1985","journal-title":"Kidney Int."},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"R110","DOI":"10.1186\/cc13899","article-title":"Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study","volume":"18","author":"Frazee","year":"2014","journal-title":"Crit Care."},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nbt.1625","article-title":"Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium","volume":"28","author":"Dieterle","year":"2010","journal-title":"Nat Biotechnol."},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.273.7.4135","article-title":"Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury","volume":"273","author":"Ichimura","year":"1998","journal-title":"J Biol Chem."},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1172\/JCI34487","article-title":"Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells","volume":"118","author":"Ichimura","year":"2008","journal-title":"J Clin Invest."},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"F552","DOI":"10.1152\/ajprenal.00285.2002","article-title":"Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury","volume":"286","author":"Ichimura","year":"2004","journal-title":"Am J Physiol Renal Physiol."},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"F517","DOI":"10.1152\/ajprenal.00291.2005","article-title":"Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury","volume":"290","author":"Vaidya","year":"2006","journal-title":"Am J Physiol Renal Physiol."},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1093\/ndt\/gfp010","article-title":"Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more","volume":"24","author":"Bonventre","year":"2009","journal-title":"Nephrol Dial Transplant."},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/toxsci\/kfm260","article-title":"Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium","volume":"101","author":"Zhou","year":"2008","journal-title":"Tox Sci."},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt.1623","article-title":"Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies","volume":"28","author":"Vaidya","year":"2010","journal-title":"Nat Biotechnol."},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"F1136","DOI":"10.1152\/ajprenal.00541.2007","article-title":"Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time","volume":"296","author":"Kramer","year":"2009","journal-title":"Am J Physiol Renal Physiol."},{"key":"R24-20230814","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tox.2007.12.031","article-title":"Validation of putative genomic biomarkers of nephrotoxicity in rats","volume":"246","author":"Wang","year":"2008","journal-title":"Toxicology."},{"key":"R25-20230814","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00280-015-2880-y","article-title":"Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients","volume":"76","author":"Shinke","year":"2015","journal-title":"Cancer Chemother Pharmacol."},{"key":"R26-20230814","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/toxsci\/kfw077","article-title":"Detection of drug-induced acute kidney injury in humans using urinary KIM-1, miR-21, -200c, and -423","volume":"152","author":"Pavkovic","year":"2016","journal-title":"Toxicol Sci."},{"key":"R27-20230814","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/cpt.606","article-title":"Profiling of kidney injury biomarkers in patients receiving cisplatin: time-dependent changes in the absence of clinical nephrotoxicity","volume":"101","author":"George","year":"2017","journal-title":"Clin Pharmacol Ther."},{"key":"R28-20230814","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/0004563214528312","article-title":"Does the kidney injury molecule-1 predict cisplatin-induced kidney injury in early stage?","volume":"52","author":"Tekce","year":"2015","journal-title":"Ann Clin Biochem."},{"key":"R29-20230814","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tox.2016.06.011","article-title":"Early prediction of cisplatin-induced nephrotoxicity by urinary vanin-1 in patients with urothelial carcinoma","volume":"359\u2013360","author":"Hosohata","year":"2016","journal-title":"Toxicology."},{"key":"R30-20230814","doi-asserted-by":"crossref","first-page":"e43809","DOI":"10.1371\/journal.pone.0043809","article-title":"Mechanism-based urinary biomarkers to identify the potential for aminoglycoside-induced nephrotoxicity in premature neonates: a proof-of-concept study","volume":"7","author":"McWilliam","year":"2012","journal-title":"PLoS One."},{"key":"R31-20230814","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1172\/JCI106083","article-title":"Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of beta-2-macroglobulin, albumin, and total protein","volume":"48","author":"Peterson","year":"1969","journal-title":"J Clin Invest."},{"key":"R32-20230814","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.kjms.2012.10.004","article-title":"Urinary neutrophil gelatinase-associated lipocalin levels predict cisplatin-induced acute kidney injury better than albuminuria or urinary cystatin C levels","volume":"29","author":"Lin","year":"2013","journal-title":"Kaohsiung J Med Sci."},{"key":"R33-20230814","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00257365","article-title":"Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose","volume":"21","author":"Daugaard","year":"1988","journal-title":"Cancer Chemother Pharmacol."},{"key":"R34-20230814","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/clpt.1988.132","article-title":"Renal tubular function in patients treated with high-dose cisplatin","volume":"44","author":"Daugaard","year":"1988","journal-title":"Clin Pharmacol Ther."},{"key":"R35-20230814","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000368515","article-title":"Administration of cyclosporine A in pregnant rats-the effect on blood pressure and on the glomerular number in their offspring","volume":"40","author":"Slabiak-Blaz","year":"2015","journal-title":"Kidney Blood Press Res."},{"key":"R36-20230814","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejphar.2013.02.039","article-title":"Sildenafil protects against nitric oxide deficiency-related nephrotoxicity in cyclosporine A treated rats","volume":"705","author":"Abdel-latif","year":"2013","journal-title":"Eur J Pharmacol."},{"key":"R37-20230814","doi-asserted-by":"crossref","first-page":"17","DOI":"10.6002\/ect.2012.0126","article-title":"Effect of reduced form of coenzyme Q10 on cyclosporine nephrotoxicity","volume":"11","author":"Sato","year":"2013","journal-title":"Exp Clin Transplant."},{"key":"R38-20230814","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.trim.2015.11.001","article-title":"The protective effect of neutralizing high-mobility group box1 against chronic cyclosporine nephrotoxicity in mice","volume":"34","author":"Park","year":"2016","journal-title":"Transpl Immunol."},{"key":"R39-20230814","first-page":"163","article-title":"Beta 2-microglobulin: its significance and clinical usefulness","volume":"20","author":"Bethea","year":"1990","journal-title":"Ann Clin Lab Sci."},{"key":"R40-20230814","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/1535370217745302","article-title":"Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy","volume":"243","author":"George","year":"2018","journal-title":"Exp Biol Med (Maywood)."},{"key":"R41-20230814","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00544087","article-title":"Follow-up study of enzymuria and beta 2 microglobulinuria during cis-platinum treatment","volume":"29","author":"Tirelli","year":"1985","journal-title":"Eur J Clin Pharmacol."},{"key":"R42-20230814","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00258126","article-title":"Beta-2-microglobulin excretion: an indicator of long term nephrotoxicity during cis-platinum treatment?","volume":"14","author":"Sorensen","year":"1985","journal-title":"Cancer Chemother Pharmacol."},{"key":"R43-20230814","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00254051","article-title":"Assessment of renal function during high-dose cis-platinum therapy in patients with ovarian carcinoma","volume":"8","author":"Buamah","year":"1982","journal-title":"Cancer Chemother Pharmacol."},{"issue":"6 suppl 1","key":"R44-20230814","first-page":"105","article-title":"Serum beta-2-microglobulin (beta-2-M) levels in heart transplant patients (HTP)","volume":"37","author":"Grzeszczak","year":"1996","journal-title":"J Cardiovasc Surg (Torino)."},{"key":"R45-20230814","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1432-2277.1991.tb01968.x","article-title":"Serum levels of alpha-1 microglobulin and beta-2 microglobulin in bone marrow transplant recipients treated with cyclosporin A","volume":"4","author":"Duraj","year":"1991","journal-title":"Transpl Int."},{"key":"R46-20230814","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ki.1986.125","article-title":"Side effects of cyclosporin A treatment in patients with rheumatoid arthritis","volume":"29","author":"Berg","year":"1986","journal-title":"Kidney Int."},{"key":"R47-20230814","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000185318","article-title":"Beta-2-microglobulin for differentiation between ciclosporin A nephrotoxicity and graft rejection in renal transplant recipients","volume":"51","author":"Prischl","year":"1989","journal-title":"Nephron."},{"key":"R48-20230814","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000187837","article-title":"Changes of urinary beta-2-microglobulin after renal transplantation","volume":"66","author":"Simic-Ogrizovic","year":"1994","journal-title":"Nephron."},{"key":"R49-20230814","first-page":"255","article-title":"Glomerular proteinuria as an early sign of renal-transplant rejection","volume":"35","author":"Steinhoff","year":"1991","journal-title":"Clin Nephrol."},{"key":"R50-20230814","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1053\/j.ajkd.2006.01.034","article-title":"Urinary beta2-microglobulin is associated with acute renal allograft rejection","volume":"47","author":"Oetting","year":"2006","journal-title":"Am J Kidney Dis."},{"key":"R51-20230814","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fmed.2017.00073","article-title":"Rediscovering beta-2 microglobulin as a biomarker across the spectrum of kidney diseases","volume":"4","author":"Argyropoulos","year":"2017","journal-title":"Front Med (Lausanne)."},{"key":"R52-20230814","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1600-6143.2005.00766.x","article-title":"Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts","volume":"5","author":"Schaub","year":"2005","journal-title":"Am J Transpl."},{"key":"R53-20230814","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1177\/0192623314524489","article-title":"Comparison between male and female Sprague-Dawley rats in the response of urinary biomarkers to injury induced by gentamicin","volume":"42","author":"Gautier","year":"2014","journal-title":"Toxicol Pathol."},{"key":"R54-20230814","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000457739","article-title":"Urinary excretion of N-acetyl-glucosaminidase and beta-2-microglobulin as early markers of gentamicin nephrotoxicity in neonates","volume":"10","author":"Gouyon","year":"1987","journal-title":"Dev Pharmacol Ther."},{"key":"R55-20230814","first-page":"530","article-title":"The significance of beta-2 microglobulinuria associated with gentamicin therapy","volume":"11","author":"Kaye","year":"1981","journal-title":"Ann Clin Lab Sci."},{"key":"R56-20230814","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ki.1980.77","article-title":"Patterns of urinary beta 2-microglobulin excretion by patients treated with aminoglycosides","volume":"17","author":"Schentag","year":"1980","journal-title":"Kidney Int."},{"key":"R57-20230814","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/adc.65.7.732","article-title":"Nephrotoxicity after ifosfamide","volume":"65","author":"Skinner","year":"1990","journal-title":"Arch Dis Child."},{"key":"R58-20230814","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1097\/QAD.0000000000001070","article-title":"Urinary beta2 microglobulin can predict tenofovir disoproxil fumarate-related renal dysfunction in HIV-1-infected patients who initiate tenofovir disoproxil fumarate-containing antiretroviral therapy","volume":"30","author":"Nishijima","year":"2016","journal-title":"AIDS."},{"key":"R59-20230814","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/s10156-013-0576-y","article-title":"Urinary beta-2 microglobulin and alpha-1 microglobulin are useful screening markers for tenofovir-induced kidney tubulopathy in patients with HIV-1 infection: a diagnostic accuracy study","volume":"19","author":"Nishijima","year":"2013","journal-title":"J Infect Chemother."},{"key":"R60-20230814","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/1357-2725(95)00027-M","article-title":"Clusterin: physiologic and pathophysiologic considerations","volume":"27","author":"Rosenberg","year":"1995","journal-title":"Int J Biochem Cell Biol."},{"key":"R61-20230814","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10735-006-9052-7","article-title":"Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control","volume":"37","author":"Shannan","year":"2006","journal-title":"J Mol Histol."},{"key":"R62-20230814","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nbt.1622","article-title":"Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury","volume":"28","author":"Dieterle","year":"2010","journal-title":"Nat Biotechnol."},{"key":"R63-20230814","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/toxsci\/kft330","article-title":"Evaluation of the relative performance of 12 urinary biomarkers for renal safety across 22 rat sensitivity and specificity studies","volume":"138","author":"Vlasakova","year":"2014","journal-title":"Toxicol Sci."},{"key":"R64-20230814","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00441-002-0629-5","article-title":"Urinary clusterin levels in the rat correlate with the severity of tubular damage and may help to differentiate between glomerular and tubular injuries","volume":"310","author":"Hidaka","year":"2002","journal-title":"Cell Tissue Res."},{"key":"R65-20230814","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/toxsci\/kfr112","article-title":"Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat","volume":"122","author":"Harpur","year":"2011","journal-title":"Toxicol Sci."},{"key":"R66-20230814","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1271\/bbb.80677","article-title":"Differential expression of plasma proteins in cyclosporine A-induced rat acute nephrotoxicity","volume":"73","author":"Shu","year":"2009","journal-title":"Biosci Biotechnol Biochem."},{"key":"R67-20230814","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1177\/0192623312444765","article-title":"Tissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in rats","volume":"40","author":"Vinken","year":"2012","journal-title":"Toxicol Pathol."},{"key":"R68-20230814","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3181\/00379727-202-43564","article-title":"Urinary clusterin in chronic nephrotoxicity in the rat","volume":"202","author":"Eti","year":"1993","journal-title":"Proc Soc Exp Biol Med."},{"key":"R69-20230814","doi-asserted-by":"crossref","first-page":"e80271","DOI":"10.1371\/journal.pone.0080271","article-title":"Circulating serum trefoil factor 3 (TFF3) is dramatically increased in chronic kidney disease","volume":"8","author":"Du","year":"2013","journal-title":"PLoS One."},{"key":"R70-20230814","doi-asserted-by":"crossref","first-page":"e0138312","DOI":"10.1371\/journal.pone.0138312","article-title":"Trefoil factor 1 excretion is increased in early stages of chronic kidney disease","volume":"10","author":"Lebherz-Eichinger","year":"2015","journal-title":"PLoS One."},{"key":"R71-20230814","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000330699","article-title":"Trefoil factor 3 predicts incident chronic kidney disease: a case-control study nested within the Atherosclerosis Risk in Communities (ARIC) study","volume":"34","author":"Astor","year":"2011","journal-title":"Am J Nephrol."},{"key":"R72-20230814","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1681\/ASN.2013010019","article-title":"Analysis of a urinary biomarker panel for incident kidney disease and clinical outcomes","volume":"24","author":"O'Seaghdha","year":"2013","journal-title":"J Am Soc Nephrol."},{"key":"R73-20230814","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nbt.1624","article-title":"Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury","volume":"28","author":"Yu","year":"2010","journal-title":"Nat Biotechnol."},{"key":"R74-20230814","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/0192623313492044","article-title":"Tissue expression and correlation of a panel of urinary biomarkers following cisplatin-induced kidney injury","volume":"42","author":"Wadey","year":"2014","journal-title":"Toxicol Pathol."},{"key":"R75-20230814","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/jcp.14.2.172","article-title":"The occurrence of post-gamma protein in urine: a new protein abnormality","volume":"14","author":"Butler","year":"1961","journal-title":"J Clin Pathol."},{"key":"R76-20230814","first-page":"387","article-title":"Cystatin C: a promising marker and predictor of impaired renal function","volume":"36","author":"Westhuyzen","year":"2006","journal-title":"Ann Clin Lab Sci."},{"key":"R77-20230814","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF03347201","article-title":"Thyroid function differently affects serum cystatin C and creatinine concentrations","volume":"28","author":"Manetti","year":"2005","journal-title":"J Endocrinol Invest."},{"key":"R78-20230814","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1093\/clinchem\/47.11.2055","article-title":"Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients","volume":"47","author":"Risch","year":"2001","journal-title":"Clin Chem."},{"key":"R79-20230814","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0009-8981(02)00044-X","article-title":"Glucocorticoids and increased serum cystatin C concentrations","volume":"320","author":"Risch","year":"2002","journal-title":"Clinica Chim Acta."},{"key":"R80-20230814","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/00365518509160980","article-title":"The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate","volume":"45","author":"Simonsen","year":"1985","journal-title":"Scand J Clin Lab Invest."},{"key":"R81-20230814","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1373\/clinchem.2005.051557","article-title":"Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children","volume":"51","author":"Grubb","year":"2005","journal-title":"Clin Chem."},{"key":"R82-20230814","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.clinbiochem.2005.05.012","article-title":"Serum cystatin C level as a potentially good marker for impaired kidney function","volume":"38","author":"Uzun","year":"2005","journal-title":"Clin Biochem."},{"key":"R83-20230814","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijcard.2004.04.009","article-title":"Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization","volume":"102","author":"Artunc","year":"2005","journal-title":"Int J Cardiol."},{"key":"R84-20230814","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2004.09.025","article-title":"Cystatin C as a marker of GFR--history, indications, and future research","volume":"38","author":"Filler","year":"2005","journal-title":"Clin Biochem."},{"key":"R86-20230814","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.fct.2012.03.077","article-title":"Ameliorative effects of SLC22A2 gene polymorphism 808 G\/T and cimetidine on cisplatin-induced nephrotoxicity in Chinese cancer patients","volume":"50","author":"Zhang","year":"2012","journal-title":"Food Chem Toxicol."},{"key":"R87-20230814","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000469715","article-title":"Dexamethasone modifies cystatin c-based diagnosis of acute kidney injury during cisplatin-based chemotherapy","volume":"42","author":"Pianta","year":"2017","journal-title":"Kidney Blood Press Res."},{"key":"R88-20230814","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000092485","article-title":"Cystatin C\u2014a marker for assessment of the glomerular filtration rate in patients with cisplatin chemotherapy","volume":"29","author":"Benohr","year":"2006","journal-title":"Kidney Blood Press Res."},{"key":"R89-20230814","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/pbc.26043","article-title":"Cystatin C based equation accurately estimates glomerular filtration rate in children with solid and central nervous system tumours: enough evidence to change practice?","volume":"63","author":"Dodgshun","year":"2016","journal-title":"Pediatr Blood Cancer."},{"key":"R90-20230814","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3109\/0886022X.2014.918813","article-title":"Correlation of Cystatin-C and radionuclidic measurement method of glomerular filtration rate in patients with lung cancer receiving cisplatin treatment","volume":"36","author":"Oc","year":"2014","journal-title":"Ren Fail."},{"key":"R91-20230814","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3109\/0886022X.2013.777929","article-title":"Evaluation of the renal function using cystatin C level in the patients receiving cisplatin-based chemotherapy","volume":"35","author":"Kos","year":"2013","journal-title":"Ren Fail."},{"key":"R92-20230814","first-page":"1635","article-title":"Accuracy of cystatin C for the detection of abnormal renal function in children undergoing chemotherapy for malignancy: a systematic review using individual patient data","volume":"26","author":"Whiting","year":"2018","journal-title":"Support Care Cancer."},{"key":"R93-20230814","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40199-016-0149-6","article-title":"Comparison between a serum creatinine-and a cystatin C-based glomerular filtration rate equation in patients receiving amphotericin B","volume":"24","author":"Karimzadeh","year":"2016","journal-title":"Daru."},{"key":"R94-20230814","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2214\/AJR.07.2356","article-title":"I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity","volume":"189","author":"Poletti","year":"2007","journal-title":"AJR Am J Roentgenol."},{"key":"R95-20230814","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5414\/CNP61098","article-title":"Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media","volume":"61","author":"Rickli","year":"2004","journal-title":"Clin Nephrol."},{"key":"R96-20230814","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/pbc.25137","article-title":"Assessment of renal function during high-dose methotrexate treatment in children with acute lymphoblastic leukemia","volume":"61","author":"Ylinen","year":"2014","journal-title":"Pediatr Blood Cancer."},{"key":"R97-20230814","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2710.2008.00932.x","article-title":"Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin","volume":"33","author":"Halacova","year":"2008","journal-title":"J Clin Pharm Ther."},{"key":"R98-20230814","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3109\/0886022X.2013.815091","article-title":"Evaluation of colistin nephrotoxicity administered at different doses in the rat model","volume":"35","author":"Ghlissi","year":"2013","journal-title":"Ren Fail."},{"key":"R99-20230814","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00467-016-3450-1","article-title":"Serum cystatin C for acute kidney injury evaluation in children treated with aminoglycosides","volume":"32","author":"Lau","year":"2017","journal-title":"Pediatr Nephrol."},{"key":"R100-20230814","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/phar.2149","article-title":"Innovative use of novel biomarkers to improve the safety of renally-eliminated and nephrotoxic medications","volume":"38","author":"Barreto","year":"2018","journal-title":"Pharmacotherapy."},{"issue":"suppl 2","key":"R101-20230814","doi-asserted-by":"crossref","first-page":"S370","DOI":"10.1086\/374751","article-title":"Interleukin-18 and host defense against infection","volume":"187","author":"Dinarello","year":"2003","journal-title":"J Infect Dis."},{"key":"R102-20230814","first-page":"224","article-title":"IL-18 in autoimmunity: review","volume":"17","author":"Boraschi","year":"2006","journal-title":"Eur Cytokine Netw."},{"key":"R103-20230814","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1172\/JCI12089","article-title":"Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure","volume":"107","author":"Melnikov","year":"2001","journal-title":"J Clin Invest."},{"key":"R104-20230814","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1172\/JCI0215623","article-title":"Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice","volume":"110","author":"Melnikov","year":"2002","journal-title":"J Clin Invest."},{"key":"R105-20230814","doi-asserted-by":"crossref","first-page":"F1414","DOI":"10.1152\/ajprenal.90288.2008","article-title":"Interleukin-18 (IL-18) binding protein transgenic mice are protected against ischemic AKI","volume":"295","author":"He","year":"2008","journal-title":"Am J Physiol Renal Physiol."},{"key":"R106-20230814","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1681\/ASN.2008020170","article-title":"IL-18 contributes to renal damage after ischemia-reperfusion","volume":"19","author":"Wu","year":"2008","journal-title":"J Am Soc Nephrol."},{"key":"R107-20230814","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/jpet.107.119792","article-title":"Cisplatin-induced ARF is associated with an increase in the cytokines IL-1\u00e2, IL-18, IL-6 and neutrophil infiltration in the kidney","volume":"322","author":"Faubel","year":"2007","journal-title":"J Pharmacol Exp Ther."},{"key":"R108-20230814","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/ki.2012.226","article-title":"Signaling through the interleukin-18 receptor alpha attenuates inflammation in cisplatin-induced acute kidney injury","volume":"82","author":"Nozaki","year":"2012","journal-title":"Kidney Int."},{"key":"R109-20230814","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/ckj\/sfx007","article-title":"Early detection of acute cisplatin nephrotoxicity: interest of urinary monitoring of proximal tubular biomarkers","volume":"10","author":"Bunel","year":"2017","journal-title":"Clin Kidney J."},{"key":"R110-20230814","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pbc.26538","article-title":"Urine biomarkers of acute kidney injury in noncritically ill, hospitalized children treated with chemotherapy","volume":"64","author":"Sterling","year":"2017","journal-title":"Pediatr Blood Cancer."},{"key":"R111-20230814","first-page":"c176","article-title":"Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography","volume":"108","author":"Ling","year":"2008","journal-title":"Nephron."},{"key":"R112-20230814","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3892\/etm.2014.1898","article-title":"Urinary interleukin-18 as an early indicator to predict contrast-induced nephropathy in patients undergoing percutaneous coronary intervention","volume":"8","author":"He","year":"2014","journal-title":"Exp Ther Med."},{"key":"R113-20230814","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1681\/ASN.2006080882","article-title":"Dual action of neutrophil gelatinase-associated lipocalin","volume":"18","author":"Schmidt-Ott","year":"2007","journal-title":"J Am Soc Nephrol."},{"key":"R114-20230814","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1097\/01.ASN.0000088027.54400.C6","article-title":"Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury","volume":"14","author":"Mishra","year":"2003","journal-title":"J Am Soc Nephrol."},{"key":"R115-20230814","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000078452","article-title":"Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity","volume":"24","author":"Mishra","year":"2004","journal-title":"Am J Nephrol."},{"key":"R116-20230814","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1681\/ASN.2010111163","article-title":"Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery","volume":"22","author":"Parikh","year":"2011","journal-title":"J Am Soc Nephrol."},{"key":"R117-20230814","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1681\/ASN.2010121302","article-title":"Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery","volume":"22","author":"Parikh","year":"2011","journal-title":"J Am Soc Nephrol."},{"key":"R118-20230814","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11010-014-2171-7","article-title":"KIM-1 and NGAL as biomarkers of nephrotoxicity induced by gentamicin in rats","volume":"397","author":"Luo","year":"2014","journal-title":"Mol Cell Biochem."},{"key":"R119-20230814","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2131\/jts.38.269","article-title":"Neutrophil gelatinase-associated lipocalin, a sensitive urinary biomarker of acute kidney injury in dogs receiving gentamicin","volume":"38","author":"Kai","year":"2013","journal-title":"J Toxicol Sci."},{"key":"R120-20230814","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1139\/cjpp-2014-0459","article-title":"Protective effects of curcumin on acute gentamicin-induced nephrotoxicity in rats","volume":"93","author":"He","year":"2015","journal-title":"Can J Physiol Pharmacol."},{"key":"R121-20230814","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tox.2010.08.013","article-title":"Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity","volume":"277","author":"Hoffmann","year":"2010","journal-title":"Toxicology."},{"key":"R122-20230814","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.1128\/AAC.01079-15","article-title":"Role of urine neutrophil gelatinase-associated lipocalin in the early diagnosis of amphotericin B-induced acute kidney injury","volume":"59","author":"Rocha","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"R123-20230814","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.biocel.2008.03.014","article-title":"Netrin-1: diversity in development","volume":"41","author":"Bradford","year":"2009","journal-title":"Int J Biochem Cell Biol."},{"key":"R124-20230814","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.transproceed.2009.11.040","article-title":"Netrin-1: a novel universal biomarker of human kidney injury","volume":"42","author":"Ramesh","year":"2010","journal-title":"Transplant Proc."},{"key":"R125-20230814","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1016\/j.bbadis.2017.09.010","article-title":"Netrins and Semaphorins: novel regulators of the immune response","volume":"1863","author":"Feinstein","year":"2017","journal-title":"Biochim Biophys Acta."},{"key":"R126-20230814","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cca.2015.03.017","article-title":"L-FABP: a novel biomarker of kidney disease","volume":"445","author":"Xu","year":"2015","journal-title":"Clin Chim Acta."},{"key":"R127-20230814","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.2353\/ajpath.2009.080780","article-title":"Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage","volume":"174","author":"Yokoyama","year":"2009","journal-title":"Am J Path."},{"key":"R128-20230814","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/aid.2013.0070","article-title":"Urine liver-type fatty acid-binding protein and kidney injury molecule-1 in HIV-infected patients receiving combined antiretroviral treatment based on tenofovir","volume":"30","author":"Jablonowska","year":"2014","journal-title":"AIDS Res Hum Retroviruses."},{"key":"R129-20230814","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ki.2008.206","article-title":"Urinary exosomal transcription factors, a new class of biomarkers for renal disease","volume":"74","author":"Zhou","year":"2008","journal-title":"Kidney Int."},{"key":"R130-20230814","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/sj.ki.5001874","article-title":"Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury","volume":"70","author":"Zhou","year":"2006","journal-title":"Kidney Int."},{"key":"R131-20230814","doi-asserted-by":"crossref","first-page":"E1043","DOI":"10.3390\/ijms17071043","article-title":"Clinical application of human urinary extracellular vesicles in kidney and urologic diseases","volume":"17","author":"De Palma","year":"2016","journal-title":"Int J Mol Sci."},{"key":"R132-20230814","first-page":"16","article-title":"Cell-cycle arrest and acute kidney injury: the light and the dark sides","volume":"16","author":"Kellum","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"R133-20230814","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/cc12503","article-title":"Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury","volume":"17","author":"Kashani","year":"2013","journal-title":"Crit Care."},{"key":"R134-20230814","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1164\/rccm.201401-0077OC","article-title":"Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication","volume":"189","author":"Bihorac","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"key":"R135-20230814","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1681\/ASN.2014060556","article-title":"Tissue inhibitor metalloproteinase-2 (TIMP2)IGF-Binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI","volume":"26","author":"Koyner","year":"2014","journal-title":"J Am Soc Nephrol."},{"key":"R136-20230814","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12871-016-0244-8","article-title":"Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers","volume":"16","author":"Dusse","year":"2016","journal-title":"BMC Anesthesiol."},{"key":"R137-20230814","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00467-017-3655-y","article-title":"Kinetics of the cell cycle arrest biomarkers (TIMP2*IGFBP-7) for prediction of acute kidney injury in infants after cardiac surgery","volume":"32","author":"Gist","year":"2017","journal-title":"Pediatr Nephrol."},{"key":"R138-20230814","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00134-016-4670-3","article-title":"Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial","volume":"43","author":"Meersch","year":"2017","journal-title":"Intensive Care Med."},{"key":"R139-20230814","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.ajkd.2015.12.033","article-title":"Clinical use of the urine biomarker [TIMP-2] x [IGFBP7] for acute kidney injury risk assessment","volume":"68","author":"Vijayan","year":"2016","journal-title":"Am J Kidney Dis."},{"key":"R140-20230814","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s11255-017-1556-4","article-title":"Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients","volume":"49","author":"Toprak","year":"2017","journal-title":"Int Urol Nephrol."},{"key":"R141-20230814","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/IJNRD.S135271","article-title":"Urinary TIMP2IGFBP7 for the prediction of platinum-induced acute renal injury","volume":"10","author":"Schanz","year":"2017","journal-title":"Int J Nephrol Renovasc Dis."},{"issue":"suppl 1","key":"R142-20230814","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/FTD.0000000000000287","article-title":"Barcelona Consensus on biomarker-based immunosuppressive drugs management in solid organ transplantation","volume":"38","author":"Brunet","year":"2016","journal-title":"Ther Drug Monit."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007691-201904000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T18:35:18Z","timestamp":1692038118000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201904000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":140,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000589","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}